YTK-105

CAS No. 774192-20-0

YTK-105( —— )

Catalog No. M37597 CAS No. 774192-20-0

YTK-105 is a ligand targeting autophagy that binds to p62.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 61 In Stock
10MG 93 In Stock
25MG 188 In Stock
50MG 310 In Stock
100MG 496 In Stock
200MG 706 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    YTK-105
  • Note
    Research use only, not for human use.
  • Brief Description
    YTK-105 is a ligand targeting autophagy that binds to p62.
  • Description
    YTK-105 is a ligand targeting autophagy that binds to p62.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    774192-20-0
  • Formula Weight
    257.33
  • Molecular Formula
    C16H19NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OCCNCC=1C=CC=C(OCC=2C=CC=CC2)C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (Pyr5,N-Me-Phe8,Sar9...

    [Glp5,(Me)Phe8,Sar9] Substance P (5-11) (DiMe-C7) is a Substance P analogue that has approximately the same effects as Substance P on neurokinin 1 receptor (NK1R) in rat brain, but with a much longer duration of action. [Glp5,(Me)Phe8,Sar9] Substance P (5-11) selectively activates dopamine metabolism in the mesencephalon and midbrain cortex of the rat brain. [Glp5,(Me)Phe8,Sar9] Substance P (5-11) also increases motor activity and induces recovery of addictive agent-seeking behavior in rats.

  • (2R,3S,11bS)-Dihydro...

    (2R,3S,11bS)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-ol is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder.

  • 4-Methoxycoumarine

    4-Methoxycoumarine has antitumour effects.Coumarin has antitumour effects in vivo and cytostatic effects in vitro. Its half-life in humans is short (1-1.5 h) and the monohydroxylated biotransformation products have significantly longer half-lives.